Disc sets up polycythemia vera challenge but Silence maintains lead
Disc Medicine presents a competitive challenge in polycythemia vera, but Silence Therapeutics maintains its lead in the space.
Silence Therapeutics
Silence Therapeutics is a biopharmaceutical company.
Company Info
Sector:Biopharma
Headquarters:United States
Founded:2000
Recent News
Silence brings the noise to Takeda with phase 2 blood cancer win
Silence brings the noise to Takeda with phase 2 blood cancer win
Silence causes uproar in rare blood cancer space as data sets high bar for competitors
Silence causes uproar in rare blood cancer space as data sets high bar for competitors
Silence spells out Phase 2 success for gene-silencing drug in rare blood cancer
Silence spells out Phase 2 success for gene-silencing drug in rare blood cancer